DSTU2 FHIR Release 3 (STU)

This page is part of the FHIR Specification (v1.0.2: DSTU (v3.0.2: STU 2). 3). The current version which supercedes this version is 5.0.0 . For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B R4 R3 R2 R3 R2

Medicationdispenseexample8

Pharmacy Work Group Maturity Level : N/A Ballot Status : Informative Compartments : Patient , Practitioner

This is the narrative for the resource. See also the XML or JSON format. This example conforms to the profile MedicationDispense .

Capecitabine (Recurrent/Metastatic) Generated Narrative with Details

Course: id : meddisp008

Name: Capecitabine contained :

Agent Protocols Options: status : completed

medication : id: medexample015; Capecitabine 1000-1250 mg/m^2 PO twice daily D1-14 500mg oral tablet (Xeloda) (Details : {RxNorm code '213293' = '213293', given as 'Capecitabine 500mg oral tablet (Xeloda)'}) ; isBrand

Offset: None subject : Donald Duck

Performers

- Actor OnBehalfOf
* Practitioner/f006 Organization/2.16.840.1.113883.19.5

Cycle length: Q21D authorizingPrescription : MedicationRequest/medrx0309

dosageInstruction :

 

 

Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.